IP Library Granted Patent US 6,906,180
Granted Patent B2
US 6,906,180 · App. 09/973,451 · Granted Jun 14, 2005

Genes encoding several poly(ADP-ribose) glycohydrolase (PARG) enzymes, the proteins and fragments thereof, and antibodies immunoreactive therewith

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,906,180
App. No.
09/973,451
Granted
Jun 14, 2005
Kind
B2
Abstract

The isolation and characterization of cDNAs encoding poly(ADP-ribose) glycohydrolase (PARG) enzymes and the amino acid sequences of PARGs from several species are described. PARG is involved in the cellular response to DNA damage and its proper function is associated with the body's response to neoplastic disorder inducing agents and oxidative stress. Expression vectors containing the cDNAs and cells transformed with the vectors are described. Probes and primers that hybridize with the cDNAs are described. Expression of the cDNA in E. coli results in an enzymatically active protein of about 111 kDa and an active fragment of about 59 kDa. Methods for inhibiting PARG expression or overexpressing PARG in a subject for therapeutic benefit are described. Exemplary of PARG inhibitors are anti-sense oligonucleotides. The invention has implications for treatment of neoplastic disorder, heart attack, stroke, and neurodegenerative diseases. Methods for detecting a mutant PARG allele are also described. Antibodies immunoreactive with PARGs and fragments thereof are described.

Claims (14)

1. An isolated antibody which binds specifically to a protein, which is a poly(ADP-ribose) glycohydrolase which catalyzes release of ADP-ribose from an ADP ribose polymer, encoded by a nucleotide sequence that is at least 80% identical to the nucleotide sequence set forth in SEQ ID NO: 1, wherein the protein has a molecular weight greater than 100 kilodaltons as determined by SDS PAGE.

2. The isolated antibody of claim 1 , wherein said isolated protein has the amino acid sequence set forth in SEQ ID NO: 2, 4, or 6.

3. The isolated antibody of claim 1 , encoded by a nucleotide sequence set forth in SEQ ID NO: 1, 3, or 5.

4. An isolated antibody which binds specifically to a protein, which is a poly(ADP-ribose) glycohydrolase which catalyzes release of ADP-ribose from an ADP-ribose polymer, wherein said protein comprises the amino acid sequence set forth in SEQ ID NO: 11, 12, 13 or 14, and has a molecular weight greater than 100 kilodaltons, as determined by SDS-PAGE.

5. The isolated antibody of claim 4 , which binds specifically to a protein encoded by a nucleic acid molecule, the complementary sequence of which hybridizes to the nucleotide sequence set forth in SEQ ID NO: 1 under the following conditions: prehybridization at 42° C. in 50% formamide, 0.25 M sodium phosphate buffer, pH 7.2, 0.25 M NaCl, 7% SDS, 1 mM EDTA for 10 hours, 100 ug denatured salmon sperm DNA, hybridization at 42° C. in 50% formamide, 0.25 M sodium phosphate buffer, 100 ug denatured salmon sperm DNA, pH 7.2, 0.25 M NaCl, 7% SDS, 1 mM EDTA.

6. An isolated antibody which binds specifically to a protein, which is a poly(ADP-ribose) glycohydrolase which catalyzes release of ADP-ribose from an ADP-ribose polymer, wherein said protein comprises amino acids 677-977 of SEQ ID NO: 4.

7. The isolated antibody of claim 1 , selected from the group consisting of an antibody and an antibody fragment.

8. The isolated antibody of claim 7 , wherein said antibody fragment is an Fc fragment, an Fab fragment, an Fab′ fragment, and an Fab′ (2) fragment.

9. The isolated antibody of claim 1 , wherein said antibody binds to the C terminus of said protein.

10. The isolated antibody of claim 1 , wherein said antibody binds to the N terminus of said protein.

11. The isolated antibody of claim 4 , selected from the group consisting of an antibody and an antibody fragment.

12. The isolated antibody of claim 1 , wherein said antibody fragment is an Fc fragment, an Fab fragment, an Fab′ fragment, and an Fab′ (2) fragment.

13. The isolated antibody of claim 4 , wherein said antibody binds to the C terminus of said protein.

14. The isolated antibody of claim 4 , wherein said antibody binds to the N terminus of said protein.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded Sep 20, 2021
From: BLUE TORCH FINANCE LLC
To: NIADYNE, INC.
Reel/Frame 057535/0177 →
RELEASE OF COLLATERAL ASSIGNMENT (PATENTS) Recorded Jun 17, 2019
From: DEM HOLDINGS, L.P.
To: NIADYNE, INC.
Reel/Frame 049485/0895 →
ASSIGNMENT FOR SECURITY -- PATENTS Recorded Jun 17, 2019
From: NIADYNE, INC.
To: BLUE TORCH FINANCE, LLC, AS COLLATERAL AGENT
Reel/Frame 049494/0669 →
RELEASE OF SECURITY INTEREST Recorded Jun 12, 2019
From: DEM HOLDINGS, L.P., AS AGENT FOR LENDERS
To: NIADYNE, INC.
Reel/Frame 049451/0560 →
SECURITY INTEREST Recorded Oct 20, 2016
From: NIADYNE, INC.
To: DEM HOLDINGS, L.P.
Reel/Frame 040075/0342 →